Dose & Grain Regimen Step 1: Manipulate
3.0 servings/day
0 (Refined grain baseline)
3.0 (Trial standard)
6.0 (High therapeutic)
Grain Composition Mix
3 Grains Active
Patient Baseline Biomarkers
CARDIO RISK REDUCTION
21.5%
95% CI: 16.2% - 26.8%
SCFA PRODUCTION
14.2 mmol
Propionate + Butyrate
PROJECTED LDL CHOL
124.6 mg/dL
-11.0% change
PROJECTED hs-CRP
2.21 mg/L
-31.0% change
Molecular Biological Pathway Simulation
Active Flux: 14.2 mmol SCFA/day
PHASE 01: INTESTINAL MICROBIOTA
Fiber Anaerobic Fermentation
Microbiome bacteria (*Bifidobacterium*, *Faecalibacterium*) ferment beta-glucan & arabinoxylan into short-chain fatty acids.
SCFA: 14.2 mmol/L
PHASE 02: HEPATIC REGULATION
Cholesterol Synthesis Suppression
Circulating propionate downregulates hepatic HMG-CoA reductase and stimulates bile acid excretion via FXR signaling.
LDL: -11.0%
PHASE 03: VASCULAR ENDOTHELIUM
Systemic Cytokine Clearance
Butyrate binds FFAR2/FFAR3 receptors on immune cells, inhibiting NF-κB transcription and suppressing serum hs-CRP & IL-6.
hs-CRP: -31.0%
PHASE 04: METABOLIC CLEARANCE
Insulin Sensitivity Restoration
Delayed postprandial gastric emptying and enhanced GLP-1 secretion improve insulin receptor substrate 1 (IRS-1) phosphorylation.
HOMA-IR: -18.8% (1.95)
Dose-Response Curve: Servings vs. CVD Risk
Meta-Analysis Regression
Biomarker Shifts (% from Baseline)
Current Regimen
Clinical Synthesis: Whole Grain Biological Impact Telemetry
Calibrated to 3.0 servings/day
| Biomarker / Clinical Endpoint | Baseline Value | Projected Value | Relative Delta | Target Classification |
|---|---|---|---|---|
| Cardiovascular Risk Reduction | Reference (1.00) | 21.5% | -21.5% HR | Cardioprotective Window |
| Systemic Inflammation (hs-CRP) | 3.20 mg/L | 2.21 mg/L | -31.0% | Moderate to Lower Risk Tier |
| LDL-Cholesterol | 140.0 mg/dL | 124.6 mg/dL | -11.0% | Suppressed Hepatic ApoB |
| Insulin Resistance (HOMA-IR) | 2.40 | 1.95 | -18.8% | Glycemic Control Enhanced |
| Colonic SCFA Production | 2.1 mmol/day | 14.2 mmol | +576% | Active Microbial Fermentation |
Referenced Scientific Grounding: CNN analysis of pooled observational cohorts (N > 120,000) and randomized controlled interventions on whole grain ingestion. Non-linear asymptotic protective ceiling observed above 4.5 servings/day. SCFA kinetics modeled from colonic gas chromatography trials.